（来源：中国妇女网） 转自：中国妇女网 记者从山西省朔州市山阴县相关部门了解到，2月7日凌晨，山阴县佳鹏生物科技有限公司一车间发生爆炸。经全力搜救，截至2月7日10时38分，5名被困 人员全部找到。经检查，均无生命体征。 目前，爆炸原因正在调查，相关善后工作同步展开。 ...

来源：央视新闻客户端 End 欢迎分享给你的朋友！ 出品 | 中国能源报（c ne ne rgy） 责编丨李慧颖 人民服系社主管主办 能 源 领 域 最 大 的 原 创 内 容 基 地 发行热线 010-6536 9497 中国航标报 真 010-6536 9481 传 � 人民- Dast 践行央媒使命 守望能源变革 2026年《中国能源报》 ■ O 全年定价480元|份 每周一出版 lip toil 21/ 国内邮发代号1-6 国内统一刊号为CN11—0068 回發 ack 1 14 中国超强网（含官方微博、官方微信 ）入列中央新闻网站 山西朔州山阴县一企业车间发生爆炸，致5人遇难 从山西省朔州市山阴县相关部门了解到，2月7日凌晨，山阴县佳鹏生物科技有限公司一车间发生爆炸。经全力搜救，截至2月7日10时 38分，5名被困人员全部找到。经检查，均无生命体征。 目前，爆炸原因正在调查，相关善后工作同步展开。 ...

目前，爆炸原因正在调查，相关善后工作同步展开。 （总台记者 贺威通 刘屿） 记者从山西省朔州市山阴县相关部门了解到，2月7日凌晨，山阴县佳鹏生物科技有限公司一车间发生爆炸。经全力搜救，截至2月7日10时38 分，5名被困人员全部找到。经检查，均无生命体征。 ...

据悉，2026年1月7日，深圳市亚辉龙生物科技股份有限公司（简称亚辉龙）披露签署战略合作框架协议的公告，涉嫌误导性陈述。近日，证监会已对亚辉龙 立案调查。下一步，将在全面调查的基础上依法处理，切实维护市场健康发展。 同日，亚辉龙亦发布关于收到中国证券监督管理委员会立案告知书的公告。 2月26日，证监会官网发布公告称，对亚辉龙公告涉嫌误导性陈述立案调查。 亚辉龙表示，公司于2026年2月6日收到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》，因涉嫌信息披露违法违规，根据《中华 人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司予以立案。 亚辉龙此次被查与此前披露的公告相关。1月6日晚，亚辉龙发布公告称，于近日与深圳脑机星链科技有限公司（以下简称："脑机星链"）签署了《战略合作 框架协议》。双方将通过整合脑机接口技术与临床和市场资源，共同开发脑机接口相关在研产品及推进后续市场拓展及推广。亚辉龙同时强调，本次签署的 协议为意向性约定，不涉及具体金额，无需提交公司董事会、股东大会审议。 同日，上交所就紧急向亚辉龙发送了问询函，并对亚辉龙及有关责任人予以监管警示的决定。 ...

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yahui Long Biotechnology Co., Ltd. (referred to as "Yahui Long") for suspected misleading statements related to a strategic cooperation framework agreement disclosed on January 7 [1][3]. Group 1: Investigation and Regulatory Actions - On February 6, Yahui Long received a notice from the CSRC regarding the investigation due to alleged violations of information disclosure laws [1][3]. - The CSRC emphasized that it will handle the case according to the law after a comprehensive investigation to maintain healthy market development [1]. - Yahui Long announced that its business operations are continuing normally and that it will cooperate with the CSRC during the investigation [1]. Group 2: Strategic Cooperation and Market Response - Yahui Long signed a strategic cooperation framework agreement with Shenzhen Brain Machine Starlink Technology Co., Ltd. (referred to as "Brain Machine Starlink") to develop brain-machine interface products [3][4]. - The announcement of this cooperation led to increased market attention, prompting the Shanghai Stock Exchange (SSE) to issue an inquiry letter requesting further details about the collaboration [3][5]. - Following regulatory scrutiny, Yahui Long clarified that Brain Machine Starlink's products are primarily in the early research and development stages and have not yet entered the registration phase [4][5]. Group 3: Market Performance - On January 6, the stock price of Yahui Long increased by 6.52%, with trading volume rising by 299% compared to the previous trading day [6].

Group 1 - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yahui Long Biotechnology Co., Ltd. (Yahui Long) for allegedly misleading statements in their announcement regarding a strategic cooperation framework agreement [1][2] - Yahui Long received a notice from the CSRC on February 6, 2026, indicating that the company is under investigation for violations of information disclosure laws [1] - The strategic cooperation agreement signed with Shenzhen Brain Machine Star Chain Technology Co., Ltd. is described as an intention-based agreement without specific financial commitments, which does not require board or shareholder approval [1] Group 2 - The Shanghai Stock Exchange (SSE) has sent an inquiry letter to Yahui Long and issued a regulatory warning to the company and its responsible personnel, emphasizing the need for accurate and complete information disclosure, especially regarding the hot market concept of "brain-machine interfaces" [2] - The SSE criticized Yahui Long for inconsistent statements regarding the technical path of the cooperation partner and for failing to adequately disclose risks related to cooperation feasibility and uncertainties, which are of significant concern to investors [2] - The SSE determined that Yahui Long's actions violated relevant regulations of the Shanghai Stock Exchange's listing rules and self-regulatory guidelines, holding the then Secretary of the Board, Wang Mingyang, accountable for the company's disclosure violations [2]

Group 1: Core Insights - The article highlights the ongoing efforts in Dongguan, Guangdong, to combat chronic diseases through innovative drug development using human tissue cells stored in liquid nitrogen [1] - Guangdong's service industry is projected to grow, with a target of a 4.7% increase in service sector value added by 2025, reflecting a 1.9 percentage point improvement year-on-year [1] - The province aims to enhance the quality and efficiency of its service industry, with significant growth in internet-related services (12.2%) and software and IT services (9.5%) [1] Group 2: Production Service Industry - The production service industry in Guangdong is positioned as a catalyst for industrial development, supported by nine trillion-yuan industrial clusters and 18 Fortune 500 companies [2] - The "first use, then transfer" reform for technology commercialization has been implemented, allowing researchers to utilize patents without initial fees, thus reducing financial pressure on small and medium enterprises [3] Group 3: Life Service Industry - The life service industry directly addresses consumer needs, with over 19 million registered business entities in Guangdong and a projected retail sales total of 4.6 trillion yuan by 2025 [5] - Guangdong is fostering new business models and technologies in the life service sector, including AI-driven tourism experiences and digital healthcare solutions, to enhance service quality and efficiency [6] Group 4: Policy and Development Goals - The province is committed to building a high-quality modern service industry system, focusing on strengthening finance, information transmission, software, and modern life services [6]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has initiated an investigation into Shenzhen Yahui Long Biotechnology Co., Ltd. for allegedly misleading statements in their announcements regarding a strategic cooperation framework agreement with Shenzhen Brain Machine Star Chain Technology Co., Ltd. [1] Group 1: Company Actions and Announcements - On January 6, Yahui Long announced a strategic cooperation agreement with Brain Machine Star Chain, claiming collaboration in product development, market promotion, and equity investment, highlighting the latter's focus on artificial intelligence and various technology paths [1] - Following regulatory pressure, Yahui Long issued a supplementary announcement clarifying that Brain Machine Star Chain's current research products only involve non-invasive technology and that some products are still in early research or preclinical stages [1] Group 2: Regulatory Responses - On January 7, the Shanghai Stock Exchange issued a regulatory warning to Yahui Long and related responsible parties, emphasizing the need for accurate and complete information disclosure, especially regarding the hot market concept of "brain-machine interfaces" [2] - The announcement from Yahui Long contained inconsistent statements about the technology paths of Brain Machine Star Chain and failed to adequately address key investor concerns regarding cooperation feasibility and associated risks [2] Group 3: Industry Context - Multiple listed companies have faced regulatory warnings and investigations this year for allegedly misleading statements related to market trends, including Ningbo Rongbai New Energy Technology Co., Ltd. and Ningbo Tianpu Rubber Technology Co., Ltd., indicating a broader trend of scrutiny in the industry [3] - The regulatory environment is tightening as the exchanges have taken action against several companies for "hitching a ride" on market hotspots, highlighting the importance of accurate disclosures in maintaining market integrity [3]

序号股东名称持股比例1云南乘黄生物科技有限公司70%2中科聚研干细胞有限公司30% 天眼查显示，近日，中科聚研云南细胞生物科技有限公司成立，法定代表人为苏晓坡，注册资本2000万 人民币，云南乘黄生物科技有限公司、中科聚研干细胞有限公司持股。 企业名称中科聚研云南细胞生物科技有限公司法定代表人苏晓坡注册资本2000万人民币国标行业科学研 究和技术服务业>研究和试验发展>工程和技术研究和试验发展地址云南省昆明市盘龙区东华街道办事 处席子营粮油机械厂宿舍9栋一层13号商铺企业类型有限责任公司营业期限2026-2-6至无固定期限登记 机关盘龙区市场监督管理局 来源：市场资讯 经营范围含医学研究和试验发展；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广； 生物基材料技术研发；工程和技术研究和试验发展（除人体干细胞、基因诊断与治疗技术开发和应用， 中国稀有和特有的珍贵优良品种）；生物质能技术服务；细胞技术研发和应用；生物基材料聚合技术研 发；人体干细胞技术开发和应用；人体基因诊断与治疗技术开发；信息技术咨询服务；生物基材料销 售。（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）许可项目：检验检测服 ...

例如，宁波容百新能源科技股份有限公司披露日常经营重大合同的公告涉嫌误导性陈述，收到证监会立 案调查告知书后，2月6日就收到宁波证监局《行政处罚事先告知书》，宁波证监局拟对公司及相关责任 人罚款合计950万元。 1月9日，证监会表示，宁波市天普橡胶科技股份有限公司股票价格异常波动，市场高度关注。证监会已 对公司股票交易异常波动公告涉嫌重大遗漏立案调查。 此外，今年以来，交易所还对深圳英集芯科技股份有限公司、中电科数字技术股份有限公司、杭萧钢构 股份有限公司、江西沃格光电集团股份有限公司等多家公司"蹭热点"行为采取监管警示。 记者注意到，今年以来，多家上市公司"蹭热点"涉嫌误导性陈述被交易所监管警示、证监会立案调查。 2月6日，证监会发布消息称，对深圳市亚辉龙生物科技股份有限公司（以下简称"亚辉龙"）公告涉嫌误 导性陈述立案调查。下一步，证监会将在全面调查的基础上依法处理，切实维护市场健康发展。 往前回溯，亚辉龙于1月6日收盘后发布《关于自愿披露签署战略合作框架协议的公告》称，公司与深圳 脑机星链科技有限公司（以下简称"脑机星链"）签订《战略合作框架协议》，双方将在产品研发、市场 推广以及股权投资等方面开展合作， ...